BRIVLERA
BRIVLERA
Approved
DIN Number
02452944
Drug Class
Human
Market Date
May 2, 2016
Company
HC
UCB Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02452944
AIG Number0157931002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX23 BRIVARACETAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
BRIVARACETAMActive
Strength: 25 MG
Monograph: BRIVARACETAM